Systemic Treatment During Pregnancy

  • Jennifer K. Litton
  • Richard L. Theriault


Pregnancy-associated breast cancer is defined as breast cancer diagnosed during pregnancy or during the first year postpartum. Breast cancer is one of the most common cancers during pregnancy with the frequency approaching 1 in 3,000 pregnancies. This incidence of pregnancy-related cancer is likely to become more common as more women are delaying childbirth. Breast changes during pregnancy pose some challenges to the diagnosis, monitoring, and treatment of breast cancer. Additionally, there are very few prospective studies of breast cancer at the time of diagnosis with the majority of data coming from retrospective chart reviews, anecdotes, and case reports. The incidence, diagnosis, evaluation, and systemic treatment of pregnancy-associated breast cancer will be reviewed here.


Breast Cancer Sentinel Lymph Node Biopsy Mutation Carrier Club Foot BRCA2 Mutation Carrier 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Anderson J. Mammary cancers and pregnancy. Br Med J. 1979;1:201024–7.Google Scholar
  2. 2.
    Ventura S, Martin J, Curtin S, et al. Births: final data for 1997. Natl Vital Stat Rep. 1999;47: 1–96.Google Scholar
  3. 3.
    Smith L, Dalrymple J, Leiserowitz G, et al. Obstetrical deliveries associated with maternal malignancy in California, 1992 through 1997. Am J Obstet Gynecol. 2001;184:1504–12.PubMedCrossRefGoogle Scholar
  4. 4.
    Anderson B, Petrek J, Byrd D, et al. Pregnancy influences breast cancer stage at diagnosis in women 30 years of age or younger. Ann Surg Oncol. 1996;3:204–2010.PubMedCrossRefGoogle Scholar
  5. 5.
    Noyes R, Spanos W, Montague E. Breast cancer in women aged 30 and under. Cancer. 1982;49:1302–7.PubMedCrossRefGoogle Scholar
  6. 6.
    Johannsson O, Loman N, Borg A, et al. Pregnancy-associated breast cancer in BRCA1 and BRCA2 germline mutation carriers. Lancet. 1998;352:1359–60.PubMedCrossRefGoogle Scholar
  7. 7.
    Antoniou A, Shenton A, Maher E, et al. Parity and breast cancer risk among BRCA1 and BRCA2 mutation carriers. Breast Cancer Res. 2006;8:R72.PubMedCrossRefGoogle Scholar
  8. 8.
    Tryggvadottir L, Olafsdottir E, Gudlaugsdottir S, et al. BRCA2 mutation carriers, reproductive factors and breast cancer risk. Breast Cancer Res. 2003;5:R121–5.PubMedCrossRefGoogle Scholar
  9. 9.
    Cullinane CA, Lubinski J, Neuhausen S, et al. Effect of pregnancy as a risk factor for breast cancer in BRCA1/BRCA2 mutation carriers. Int J Cancer. 2005;20107:988–91.CrossRefGoogle Scholar
  10. 10.
    Woo JC, Yu T, Hurd TC. Breast Cancer in pregnancy: a literature review. Arch Surg. 2003;138:91–8.PubMedCrossRefGoogle Scholar
  11. 2010.
    Byrd B, Bayer D, Robertson J, et al. Treatment of breast tumors associated with pregnancy and lactation. Ann Surg. 1962;155:940–7.PubMedGoogle Scholar
  12. 12.
    Collins J, Liao S, Wile A. Surgical management of breast masses associated with pregnancy and lactation. J Reprod Med. 1995;40:785–8.PubMedGoogle Scholar
  13. 13.
    Nicklas A, Baker M. Imaging strategies in the pregnant breast cancer patient. Semin Oncol. 2000;27:623–32.PubMedGoogle Scholar
  14. 14.
    Liberman L, Giess C, Dershaw D, et al. Imaging of pregnancy associated breast cancer. Radiology. 1994;191:245–8.PubMedGoogle Scholar
  15. 15.
    Samuels T, Liu F, Yaffe M, et al. Gestational breast cancer. Can Assoc Radiol J. 1998;49: 172–80.PubMedGoogle Scholar
  16. 16.
    Ishida T, Yokoe T, Kasmu F, et al. Clinicopathologic characteristics and prognosis of breast cancer patients associated with pregnancy and lactation: analysis of case control study in Japan. Jpn J Cancer Res. 1992;83:201043–9.CrossRefGoogle Scholar
  17. 17.
    Yang WT, Dryden MJ, Gwyn K, et al. Imaging of breast cancer diagnosed and treated with chemotherapy during pregnancy. Radiology. 2006;239:52–60.PubMedCrossRefGoogle Scholar
  18. 18.
    Ahn B, Kim H, Moon W, et al. Pregnancy and lactation-associated breast cancer: mammographic and sonnographic findings. J Ultrasound Med. 2003;22:491–7.PubMedGoogle Scholar
  19. 19.
    Loibl S, von Minckwitz G, Gwyn K, et al. Breast carcinoma during pregnancy. Cancer. 2006;106:237–46.PubMedCrossRefGoogle Scholar
  20. 20.
    Bottles K, Taylor R. Diagnosis of breast masses in pregnant and lactating women by aspiration cytology. Obstet Gynecol. 1985;66:76S–8S.PubMedGoogle Scholar
  21. 21.
    Gupta R, McHutchison A, Dowle C, et al. Fine-needle aspiration cytodiagnosis of breast masses in pregnant and lactating women and its impact on management. Diagn Cytopathol. 1993;9:156–9.PubMedCrossRefGoogle Scholar
  22. 22.
    Schackmuth E, Harlow C, Norton L. Milk fistula: a complication after core breast biopsy. AJR Am J Roentgenol. 1993;161:961–2.PubMedGoogle Scholar
  23. 23.
    Middleton L, Amin M, Gwyn K, et al. Breast carcinoma in pregnant women. Cancer. 2003;98:1055–60.PubMedCrossRefGoogle Scholar
  24. 24.
    Reed W, Hannisdal E, Skovlund E, et al. Pregnancy and breast cancer: a population-based study. Virchows Archiv. 2003;443:44–50.PubMedCrossRefGoogle Scholar
  25. 25.
    Bonnier P, Romain S, Dilhuydy J, et al. Influence of pregnancy on the outcome of breast cancer: a case-control study. Int J Cancer. 1997;72:720–7.PubMedCrossRefGoogle Scholar
  26. 26.
    Berry DL, Theriault RL, Holmes FA, et al. Management of breast cancer during pregnancy using a standardized protocol. J Clin Oncol. 1999;17:855.PubMedGoogle Scholar
  27. 27.
    Elledge R, Ciocca D, Langone G, et al. Estrogen receptor, progesterone receptor, and HER-2/neu protein in breast cancers from pregnant patients. Cancer. 1993;71:2499–506.PubMedCrossRefGoogle Scholar
  28. 28.
    Kuerer HM, Gwyn K, Ames FC, et al. Conservative surgery and chemotherapy for breast carcinoma during pregnancy. Surgery. 2002;131:108–10.PubMedCrossRefGoogle Scholar
  29. 29.
    Keleher A, Wendt R, Delpassand E, et al. The safety of lymphatic mapping in pregnant breast cancer patients using Tc-99m sulfur colloid. Breast J. 2004;10:492–5.PubMedCrossRefGoogle Scholar
  30. 30.
    Mazonakis M, Varveris H, Damilakis J, et al. Radiation dose to conceptus resulting from tangential breast irradiation. Int J Radiat Oncol Biol Phys. 2003;55:386–91.PubMedCrossRefGoogle Scholar
  31. 31.
    Doll D, Ringenberg Q, Yarbro J. Antineoplastic agents in pregnancy. Semin Oncol. 1989;16: 337–46.PubMedGoogle Scholar
  32. 32.
    Hahn K, Johnson P, Gordon N, et al. Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero. Cancer. 2006;107:1219–26.PubMedCrossRefGoogle Scholar
  33. 33.
    Sekar R, Stone PR. Trastuzumab use for metastatic breast cancer in pregnancy. Obstet Gynecol. 2007;20100:507–10.CrossRefGoogle Scholar
  34. 34.
    Shrim A, Garcia-Bournissen F, Maxwell C, et al. Favorable pregnancy outcome following Trastuzumab (Herceptin(R)) use during pregnancy–Case report and updated literature review. Reprod Toxicol. 2007;23:62010–3.CrossRefGoogle Scholar
  35. 35.
    Bader AA, Schlembach D, Tamussino KF, et al. Anhydramnios associated with administration of trastuzumab and paclitaxel for metastatic breast cancer during pregnancy. Lancet Oncol. 2007;8:79–81.PubMedCrossRefGoogle Scholar
  36. 36.
    Kelly H, Graham M, Humes E, et al. Delivery of a healthy baby after first-trimester maternal exposure to lapatinib. Clin Breast Cancer. 2006;7:339–41.PubMedCrossRefGoogle Scholar
  37. 37.
    Cunha G, Taguchi O, Namikawa R, et al. Teratogenic effects of clomiphene, tamoxifen and diethylstilbestrol on the developing human female genital tract. Hum Pathol. 1987;18:201032–43.CrossRefGoogle Scholar
  38. 38.
    Isaacs RJ, Hunter W, Clark K. Tamoxifen as systemic treatment of advanced breast cancer during pregnancy–Case Report and Literature Review. Gynecol Oncol. 2001;80:405–8.PubMedCrossRefGoogle Scholar
  39. 39.
    Cullins S, Pridjian G, Sutherland C. Goldenhar syndrome associated with tamoxifen given to the mother during gestation. JAMA. 1994;271:1905–6.PubMedCrossRefGoogle Scholar
  40. 40.
    Tewari K, Bonebrake RG, Asrat T, et al. Ambiguous genitalia in infant exposed to tamoxifen in utero. Lancet. 1997;350:183.PubMedCrossRefGoogle Scholar
  41. 41.
    Bilgin K, Yaramis A, Haspolat K, et al. A randomized trial of granulocyte-macrophage colony-stimulating factor in neonates with sepsis and neutropenia. Pediatrics. 2001;107:36–41.PubMedCrossRefGoogle Scholar
  42. 42.
    Schibler KR, Osborne KA, Leung LY, et al. A randomized, placebo-controlled trial of granulocyte colony-stimulating factor administration to newborn infants with neutropenia and clinical signs of early-onset sepsis. Pediatrics. 1998;102:6–13.PubMedCrossRefGoogle Scholar
  43. 43.
    Briggs G, Freeman R, Yaffee S. A reference guide to fetal and neonatal risk: drugs in pregnancy and lactation. Philadelphia: Lippincott Williams & Wilkins; 1998.Google Scholar
  44. 44.
    Durodola J. Administration of cyclophosphamide during late pregnancy and early lactation: a case report. J Natl Med Assoc. 1979;71:165–6.PubMedGoogle Scholar
  45. 45.
    Zemlickis D, Lishner M, Degendorfer P, et al. Maternal and fetal outcome after breast cancer in pregnancy. Am J Obstet Gynecol. 1992;166:781–7.PubMedGoogle Scholar
  46. 46.
    Tretli S, Kvalheim G, Thoresen S, et al. Survival of breast canecr patients diagnosed during pregnancy or lactation. Br J Cancer. 1988;58:382–4.PubMedCrossRefGoogle Scholar
  47. 47.
    Aviles A, Neri N. Hematologic malignancies and pregnancy: a final report of 84 children who received chemotherapy in utero. Clin Lymphoma. 2001;2:173–7.PubMedCrossRefGoogle Scholar
  48. 48.
    Aviles A, Neri N, Nambo MJ. Long-term evaluation of cardiac function in children who received anthracyclines during pregnancy. Ann Oncol. 2006;17:286–8.PubMedCrossRefGoogle Scholar
  49. 49.
    Mueller B, Simon M, Deapen D, et al. Childbearing and survival after breast carcinoma in young women. Cancer. 2003;98:201031–40.CrossRefGoogle Scholar
  50. 50.
    Velentgas P, Daling J, Malone K, et al. Pregnancy after breast carcinoma. Cancer. 1999;85:2424–32.PubMedCrossRefGoogle Scholar
  51. 51.
    von Schoultz E, Johansson H, Wilking N, et al. Influence of prior and subsequent pregnancy on breast cancer prognosis. J Clin Oncol. 1995;13:430–4.Google Scholar
  52. 52.
    Ives A, Saunders C, Bulsara M, et al. Pregnancy after breast cancer: population based study. BMJ. 2007;334:194.PubMedCrossRefGoogle Scholar
  53. 53.
    Kroman N, Jensen M-B, Melbye M, et al. Should women be advised against pregnancy after breast-cancer treatment? Lancet. 1997;350:319–22.PubMedCrossRefGoogle Scholar

Copyright information

© Springer New York 2010

Authors and Affiliations

  1. 1.Department of Breast Medical Oncology, Division of Cancer MedicineUniversity of Texas M. D. Anderson Cancer Center, University of TexasHoustonUSA

Personalised recommendations